The Committee for Medicinal Products for Human Use (CHMP) has recommended ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) in combination with Rekambys (rilpivirine injection) and Edurant (rilpivirine tablets) for...

4D pharma merges with SPAC in $37.6m deal

4D pharma, the listed Leeds-headquartered pharmaceutical company, has merged with Longevity, a special purpose acquisition company (SPAC), in a deal worth up to $37.6...

Cyted acquires Pathognomics Ltd to support expansion of digital pathology and diagnostic reporting services

Cyted Ltd, a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, has acquired Pathognomics Limited,...

View the Online Magazine

- Advertisement -

Launches

The Native Antigen Company launches range of SARS-CoV-2 specific antibodies

The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), suppliers of reagents that enable research into vaccines and diagnostics for emerging and...

New saliva-based COVID-19 test promises results in ten minutes

A saliva-based lateral flow COVID-19 test which promises results in ten minutes has launched in the UK. The Rapid Saliva Protein Test (RSPT) from Medusa...

Private funding sees IcanoMAB launch to develop precision mAbs

IcanoMAB, a privately-funded biotech based in Germany, has launched to develop novel precision canonical antibodies for the treatment of cancer, immune-system related diseases and...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Avacta launch COVID-19 laboratory test

Avacta Group is set to launch a high-performance test for the SARS-CoV-2 spike protein to support global efforts to combat COVID-19. Enzyme linked immunosorbent assays...

US secures 100m doses of Moderna’s COVID-19 mRNA vaccine

The US government has secured 100 million doses of Moderna’s mRNA vaccine against COVID-19. The government has paid Moderna, the Cambridge, UK-based biotech pioneering mRNA...

In brief: Sanofi & GSK in talks to supply 300m doses of COVID vaccine to EU

Sanofi and GlaxoSmithKline (GSK) are in “advanced discussions” with the European Commission (EC) for the supply of up to 300 million doses of a...

Arcturus to supply Israel with COVID-19 vaccine candidate

Arcturus Therapeutics has signed an agreement to supply the its COVID-19 vaccine candidate, LUNAR-COV1D, to the Israeli Ministry of Health. Delivery of the vaccine candidate...

Approvals

CHMP recommends ViiV’s long-acting regimen for HIV

The Committee for Medicinal Products for Human Use (CHMP) has recommended ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) in combination with Rekambys (rilpivirine injection)...

Nucala approved as first and only biologic treatment for Hypereosinophilic Syndrome

GlaxoSmithKline (GSK) has secured FDA approval for Nucala (mepolizumab) for the treatment of adult and paediatric patients aged 12 years and older with Hypereosinophilic...

Opdivo plus Yervov and chemo recommended for EU approval

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo (nivolumab) plus Yervoy (ipilimumab)...

Clear Labs granted EUA by FDA for SARS-CoV-2 novel descriptive diagnostic

The U.S. Food and Drug Administration (FDA) has granted Clear Labs Emergency Use Authorization (EUA) for its Clear Dx™ SARS-CoV-2 novel descriptive diagnostic. The...

FDA clears Roche’s BK virus quantitative test of cobas systems

Roche has secured US approval for the cobas BKV Test on the cobas 6800 and 8800 Systems to support better care for transplant patients. The...

FDA approves additional doses of Trulicity for type 2 diabetes

The US FDA has approved two additional doses of Eli Lilly’s Trulicity (dulaglutide) for the treatment of type 2 diabetes. The approval expands the label...

Manufacturiung

Manufacturing partnership for Samsung Biologics & AstraZeneca

Samsung Biologics and AstraZeneca have forged a long-term manufacturing and supply agreement, valued at approximately $330.8 million. Samsung Biologics will provide large-scale commercial manufacturing for...

Finance

4D pharma merges with SPAC in $37.6m deal

4D pharma, the listed Leeds-headquartered pharmaceutical company, has merged with Longevity, a special purpose acquisition company (SPAC), in a deal worth up to $37.6...

Cyted acquires Pathognomics Ltd to support expansion of digital pathology and diagnostic reporting services

Cyted Ltd, a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, has acquired Pathognomics Limited,...

Record quarter for UK biotech as £1bn is raised

UK biotech companies raised more than £1 billion in equity finance between June and August 2020, the highest quarter for investments in the sector...

Moderna regains rights to RSV vaccine from Merck

Moderna has regained all rights to the respiratory syncytial virus (RSV) vaccine (mRNA-1172) from Merck, including rights to develop RSV vaccines for adult populations. mRNA-1172,...

Research & Development
Latest

Takeda & Arrowhead to co-develop RNAi therapy for AATLD

Takeda and Arrowhead Pharmaceuticals will collaborate to develop ARO-AAT, a Phase 2 investigational RNA interference (RNAi) therapy in development to treat alpha-1 antitrypsin-associated liver...

AstraZeneca’s long-acting antibody combo advances into Phase III clinical trials

AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside...

EMA starts first rolling review of COVID-19 vaccine

The European Medicines Agency’s (EMA) human medicines committee (CHMP) has started the first ‘rolling review’ of a COVID-19 vaccine, which is being developed by...

Pfizer & CStone address oncological needs in China

Pfizer has formed a strategic collaboration with CStone Pharmaceuticals to address oncological needs in China. As part of the collaboration, Pfizer Hong Kong will make...

Iksuda Therapeutics enters license agreement to develop new generation of antibody drug conjugates

Iksuda Therapeutics (Iksuda), the developer of enhanced, new-generation of Antibody Drug Conjugates (ADCs), has executed its option to secure exclusive, worldwide rights to develop...

Appointments

ACG promotes Susheel Pillai as the new CEO for Inspection Business

ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, today announced the promotion of Susheel Pillai as the new...

New Chief Medical Officer for Valneva

Valneva, a specialty vaccine company based in France, has appointed Juan Carlos Jaramillo, as Chief Medical Officer and member of the Management Board. Starting 1st...

In brief: New head of R&D for Cellbox Solutions

Germany’s Cellbox Solutions has appointed Lonza Pharma and Biotech’s former Head of Biosolutions R&D as its new Head of R&D. Dr Herbert A. Mueller-Hartmann will...
- Advertisement -

Clear Labs granted EUA by FDA for SARS-CoV-2 novel descriptive diagnostic

The U.S. Food and Drug Administration (FDA) has granted Clear Labs Emergency Use Authorization (EUA) for its Clear Dx™ SARS-CoV-2 novel descriptive diagnostic. The...

FDA clears Roche’s BK virus quantitative test of cobas systems

Roche has secured US approval for the cobas BKV Test on the cobas 6800 and 8800 Systems to support better care for transplant patients. The...